Cabazitaxel

FDA Approved: * December 29, 2021
Pharm Company: * ACCORD HLTHCARE INC
Category: Cancer

Cabazitaxel, sold under the brand name Jevtana, is a semi-synthetic derivative of a natural taxoid.[2] It is a microtubule inhibitor,[1] and the fourth taxane to be approved as a cancer therapy.[citation needed] Cabazitaxel was developed by Sanofi-Aventis and was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone-refractory prostate cancer in June 2010.[3][4][5] It... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Related Brands

Drugs with the same active ingredients

Popular Topics

Cabazitaxel Information

What is the hcpc's code for Cabazitaxel? ## I am afraid you're going to have to be little more specific. I did t...

1 REPLY